ストックスクリーナーアプリを入手
22.90
3.06%
0.68
アフターアワーズ：
23.34
0.44
+1.92%
前日終値:
$22.22
開ける：
$22.34
24時間の取引高:
708.63K
Relative Volume:
2.07
時価総額：
$815.58M
収益：
$154.15M
当期純損益:
$-33.58M
株価収益率:
-23.85
EPS:
-0.96
ネットキャッシュフロー:
$-20.74M
1週間 パフォーマンス:
-12.29%
1か月 パフォーマンス:
-27.87%
6か月 パフォーマンス:
-44.65%
1年 パフォーマンス:
+117.27%
1日の値動き範囲:
$21.69
$23.02
1週間の範囲:
$21.14
$26.30
52週間の値動き範囲:
$9.30
$59.23
Harrow Inc Stock (HROW) Company Profile
HROW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
22.90 | 815.58M | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
164.39 | 73.61B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.90 | 47.03B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.39 | 46.98B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.10 | 18.45B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.24 | 13.95B | 612.78M | -86.37M | -62.91M | -0.87 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-06 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-04 | 繰り返されました | B. Riley Securities | Buy |
| 2024-04-11 | 開始されました | Craig Hallum | Buy |
| 2022-09-08 | 再開されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2021-09-24 | 開始されました | Aegis Capital | Buy |
| 2021-07-02 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Harrow Inc (HROW) 最新ニュース
Harrow shares react modestly to FDA move - Nashville Post
Harrow shares react to FDA move - Nashville Post
Harrow Signs 5-Year Supply Deal for Triesence -March 11, 2025 at 08:36 am EDT - Marketscreener.com
Major Breakthrough: Harrow Ends TRIESENCE Shortage Crisis with 5-Year Manufacturing Deal - StockTitan
Harrow (HROW) to Release Quarterly Earnings on Monday - Defense World
Rhumbline Advisers Has $1.35 Million Position in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Sold by New York State Common Retirement Fund - Defense World
When Will Harrow Report Q4 Earnings? Key Date for Eyecare Pharma Investors - StockTitan
Nicox Presents New Analysis from the NCX 470 Mont Blanc Trial and Provides Development Update - GlobeNewswire Inc.
Smallcap Eyecare Pharma Company Harrow Health Has Two Major Catalysts For 2025 - Seeking Alpha
Implied Volatility Surging for Harrow (HROW) Stock Options - Nasdaq
Harrow (NASDAQ:HROW) shareholders have earned a 40% CAGR over the last five years - Yahoo Finance
Shareholders Should Be Pleased With Harrow, Inc.'s (NASDAQ:HROW) Price - Simply Wall St
Equitable Trust Co. Sells 14,670 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 5.1%Here's What Happened - MarketBeat
Bleakley Financial Group LLC Buys 3,394 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
What is HC Wainwright's Forecast for Harrow Q4 Earnings? - MarketBeat
HC Wainwright Comments on Harrow’s Q4 Earnings (NASDAQ:HROW) - Defense World
Harrow (NASDAQ:HROW) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
H.C. Wainwright sets $57 target on Harrow Health stock - MSN
HC Wainwright & Co. Initiates Coverage of Harrow (HROW) with Buy Recommendation - MSN
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
15,448 Shares in Harrow, Inc. (NASDAQ:HROW) Acquired by Sonora Investment Management Group LLC - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 4.6%Here's What Happened - MarketBeat
Fungal Keratitis Treatment Market Growth By 2031 | Harrow Inc., - openPR
SG Americas Securities LLC Acquires 18,815 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
SG Americas Securities LLC Boosts Stake in Harrow, Inc. (NASDAQ:HROW) - Defense World
Commit To Buy Harrow At $23, Earn 18% Annualized Using Options - Nasdaq
Opaleye management sells $711,814 worth of Harrow shares - MSN
Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients - Business Wire
Harrow Launches 'Harrow Cares' Patient Support Program with Cencora Partnership - StockTitan
Harrow, Inc. (NASDAQ:HROW) Sees Board Member Resignation - Defense World
Opaleye Management Inc. Significantly Reduces Stake in Harrow Inc. - GuruFocus.com
Opaleye management sells $711,814 worth of Harrow shares By Investing.com - Investing.com South Africa
Harrow (NASDAQ:HROW) Trading Down 4.9%Time to Sell? - MarketBeat
Assenagon Asset Management S.A. Sells 79,071 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Brookstone Capital Management Invests $275,000 in Harrow, Inc. (NASDAQ:HROW) - Defense World
Brookstone Capital Management Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 4.1%Should You Sell? - MarketBeat
Harrow Inc (HROW) 財務データ
収益
当期純利益
現金流量
EPS
7.04%
大文字化:
|
ボリューム (24 時間):